Finance

Lists
1AFX:BIT
Carl Zeiss Meditec AG
31,20 €
+0,45%
(+0,14) 1D
2 ოქტ, 17:26:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1AFX...
Open
31,20 €
High
31,20 €
Low
31,20 €
Mkt. cap
2,72 მლრდ.
Avg. vol.
39,00
Volume
15,00
Dividend
1,76%
Quarterly dividend
0,14 €
Ex-dividend date
27 მარ. 2026
P/E ratio
22,71
52-wk high
48,30 €
52-wk low
22,88 €
EPS
1,37 €
No. of employees
6 ათ.
Open
31,20 €
High
31,20 €
Low
31,20 €
Mkt. cap
2,72 მლრდ.
Avg. vol.
39,00
Volume
15,00
Dividend
1,76%
Quarterly dividend
0,14 €
Ex-dividend date
27 მარ. 2026
P/E ratio
22,71
52-wk high
48,30 €
52-wk low
22,88 €
EPS
1,37 €
No. of employees
6 ათ.
News stories
From web sources and news partners
Profile
Carl Zeiss Meditec AG is a multinational medical technology company. Headquartered in Jena, Germany, the company operates as part of the larger Carl Zeiss Group. Doing business as ZEISS Medical Technology, the company develops and manufactures solutions for ophthalmology, dentistry, oncology, neurosurgery, microsurgery, and other medical applications. Wikipedia
About Carl Zeiss Meditec AG
CEOმარკუს ვებერი
Employees5,8 ათ.
Founded2002
Headquartersიენა, თიურინგია, გერმანია
SectorMedical device
Websitezeiss.com
Last report
6 აგვ. 2026
Fiscal period
Q3 2026
EPS / Est. (EUR)
0,54 € / 0,40 €
+35,00%beat
Revenue / Est. (EUR)
562,72 მლნ. / 540,72 მლნ.
+4,07%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
627,54 მლნ.
467,00 მლნ.
524,00 მლნ.
562,72 მლნ.
Cost of goods sold
295,75 მლნ.
239,80 მლნ.
260,62 მლნ.
260,44 მლნ.
Cost of revenue
295,75 მლნ.
239,80 მლნ.
260,62 მლნ.
260,44 მლნ.
Research and development expenses
91,78 მლნ.
75,50 მლნ.
89,30 მლნ.
78,94 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
169,64 მლნ.
152,00 მლნ.
150,59 მლნ.
162,39 მლნ.
Operating expense
261,40 მლნ.
227,50 მლნ.
237,90 მლნ.
240,02 მლნ.
Total operating expenses
557,15 მლნ.
467,30 მლნ.
498,52 მლნ.
500,46 მლნ.
Operating income
70,40 მლნ.
-300,00 ათ.
25,48 მლნ.
62,26 მლნ.
Other non operating income
-4,02 მლნ.
-200,00 ათ.
4,27 მლნ.
7,88 მლნ.
EBT including unusual items
67,29 მლნ.
-5,50 მლნ.
25,79 მლნ.
69,16 მლნ.
EBT excluding unusual items
62,61 მლნ.
-5,50 მლნ.
25,79 მლნ.
69,16 მლნ.
Income tax expense
13,05 მლნ.
200,00 ათ.
6,76 მლნ.
16,40 მლნ.
Effective tax rate
19,39%
-3,64%
26,21%
23,71%
Other operating expenses
-17,00 ათ.
-
-1,99 მლნ.
-1,31 მლნ.
Net income
51,81 მლნ.
-4,90 მლნ.
19,57 მლნ.
55,03 მლნ.
Net profit margin
8,26%
-1,05%
3,73%
9,78%
Earnings per share
-
0,03
0,45
0,54
Interest and investment income
570,00 ათ.
1,20 მლნ.
1,28 მლნ.
2,09 მლნ.
Interest expense
-6,30 მლნ.
-6,00 მლნ.
-6,16 მლნ.
-5,93 მლნ.
Net interest expenses
-5,73 მლნ.
-4,80 მლნ.
-4,88 მლნ.
-3,84 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
83,01 მლნ.
12,31 მლნ.
63,70 მლნ.
74,87 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები